Plain-English translation of NCT07601087 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage clinical trial (Phase I) testing a new experimental medication called , which is being developed to treat heart failure. The study will give healthy volunteers either the medication or a placebo (inactive pill) and carefully monitor how safe it is, how well their bodies tolerate it, and how their bodies process and respond to it. This is the first step in testing whether this new treatment might eventually help people with heart failure.
Before any medication can be tested in patients with heart disease, researchers need to understand whether it is safe and how the human body handles it. This early study in healthy people helps researchers gather that essential safety information before moving forward to test this medication in actual heart failure patients.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic multiple times over several weeks for physical exams, blood tests, and to take either the new medication or a placebo by mouth. The researchers will closely monitor your safety with regular check-ins and blood work to see how your body processes the medication and how it affects you. You'll need to follow specific dietary guidelines, avoid smoking and other drugs, and be available for frequent visits and blood samples to gather detailed safety information.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
China
Phase
Safety & dosing
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Enrollment target
~66 participants
Started
June 2026
Primary completion
September 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 55 Years
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kaiyun Zhang
Shandong Suncadia Medicine Co., Ltd.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.